REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/23/2025
Back to search
Official data from USPTO
CYTHERA PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CYTHERA PHARMACEUTICALS
ST13
US500000086508743Class
42
Filing
86508743
Registration
4903903
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
02/23/2025
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
01/20/2015
Registration date
02/23/2016
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2022
Last transaction
02/23/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
05/06/2014
First use in commerce
05/06/2014
Drawing code
4
Owner type
03
Owner location
Honolulu, HI
Examiner
HACK, ANDREA
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
C. P. (pessoa física)
Representatives
Cythera Pharmaceuticals
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
22 publications found
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/26/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/26/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/26/2022
ES8R
TEAS SECTION 8 RECEIVED
12/16/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/23/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
02/23/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2015
PUBO
PUBLISHED FOR OPPOSITION
12/08/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/05/2015
ALIE
ASSIGNED TO LIE
11/04/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/19/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2015
GNRT
NON-FINAL ACTION E-MAILED
04/23/2015
CNRT
NON-FINAL ACTION WRITTEN
04/23/2015
DOCK
ASSIGNED TO EXAMINER
04/23/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/31/2015
NWAP
NEW APPLICATION ENTERED
01/23/2015
Continuous trademark protection
Get notified about every new filing that threatens CYTHERA PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.